These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8658840)

  • 1. Hepatitis B immune globulin dose requirements following orthotopic liver transplantation for chronic hepatitis B cirrhosis.
    McGory R; Ishitani M; Oliveira W; Stevenson W; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1687-8. PubMed ID: 8658840
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis.
    McGory RW; Ishitani MB; Oliveira WM; Stevenson WC; Dickson RC; Caldwell SH; Pruett TL
    Transplant Proc; 1995 Feb; 27(1):1213-4. PubMed ID: 7878854
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic significance of the hepatitis B virus-DNA concentration in patients after orthotopic liver transplantation.
    Zöllner B; Polywka S; Feucht HH; Martens H; Iske L; Oehler G; Laufs R
    Hepatogastroenterology; 1994 Oct; 41(5):424-6. PubMed ID: 7851849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft.
    Ishitani M; McGory R; Dickson R; Caldwell S; Bickston S; McCullough C; Pruett T
    Transplant Proc; 1996 Jun; 28(3):1714-6. PubMed ID: 8658852
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoprophylaxis for hepatitis B virus reinfection after liver transplantation.
    Jeng LB; Lee WC; Yeh DS; Wang CC; Wang KL; Chen SC; Chen MF; Chien RN; Chiu CT; Lin DY
    Transplant Proc; 1994 Aug; 26(4):2243-4. PubMed ID: 8066736
    [No Abstract]   [Full Text] [Related]  

  • 6. Factors associated with viral breakthrough in lamivudine monoprophylaxis of hepatitis B virus recurrence after liver transplantation.
    Chan HL; Chui AK; Lau WY; Chan FK; Wong ML; Tse CH; Rao AR; Wong J; Sung JJ
    J Med Virol; 2002 Oct; 68(2):182-7. PubMed ID: 12210406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
    Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
    Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Milan multicenter experience in 96 liver transplants for hepatitis B virus-related cirrhosis.
    Caccamo L; Belli LS; Mazzaferro V; Colledan M; Alberti A; Regalia E; Fassati LR; Ideo G; Rubino A; Belli L
    Transplant Proc; 1994 Dec; 26(6):3585-7. PubMed ID: 7998283
    [No Abstract]   [Full Text] [Related]  

  • 9. Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
    Bihl F; Loggi E; Chisholm JV; Biselli M; Morelli MC; Cursaro C; Terrault NA; Bernardi M; Bertoletti A; Andreone P; Brander C
    Liver Transpl; 2008 Apr; 14(4):478-85. PubMed ID: 18324666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with the intensity of liver fibrosis in renal transplant patients with hepatitis B virus infection.
    Matos CA; Perez RM; Lemos LB; Medina-Pestana JO; Lanzoni VP; Alberto FL; Moreira ES; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):653-7. PubMed ID: 17625434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of lamivudine in patients with hepatitis B virus precore mutant infection before and after liver transplantation.
    Ben-Ari Z; Zemel R; Kazetsker A; Fraser G; Tur-Kaspa R
    Am J Gastroenterol; 1999 Mar; 94(3):663-7. PubMed ID: 10086648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term immunoprophylaxis for hepatitis B virus reinfection after liver transplantation.
    Lee WC; Jeng LB; Wang CC; Chen MF; Chien RN; Chiu CT; Ling DY; Liaw YF; Chang CH
    Transplant Proc; 1996 Jun; 28(3):1699-700. PubMed ID: 8658846
    [No Abstract]   [Full Text] [Related]  

  • 13. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load.
    Iloeje UH; Yang HI; Su J; Jen CL; You SL; Chen CJ;
    Gastroenterology; 2006 Mar; 130(3):678-86. PubMed ID: 16530509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver transplantation in patients with cirrhosis secondary to hepatitis B virus and hepatitis C virus infections].
    Lucena JF; Herrero JI
    An Sist Sanit Navar; 2004; 27 Suppl 2():91-101. PubMed ID: 15381947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis of recurrent hepatitis B in Chinese patients after liver transplantation using lamivudine combined with hepatitis B immune globulin according to the titer of antibody to hepatitis B surface antigen.
    Jiao ZY; Jiao Z
    Transplant Proc; 2007 Jun; 39(5):1533-6. PubMed ID: 17580182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the changes of HBV serum markers and HBV DNA and the effects of perioperative factors after liver transplantation].
    Tang YM; Chen GH; He XS; Zhu XF; Chen MH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Mar; 13(3):164-7. PubMed ID: 15760545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term passive immunoprophylaxis of B virus recurrence after liver transplantation in HBs antigen-positive patients.
    Gugenheim J; Crafa F; Fabiani P; Goubaux B; Ouzan D; Mouiel J
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1349-50. PubMed ID: 8442140
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development of cirrhosis after chronic hepatitis B].
    Hazama H; Koga M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():354-7. PubMed ID: 15453345
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mutants of the pre-c region of the hepatitis B virus associated with severe recurrence after liver transplantation].
    Féray C
    Gastroenterol Clin Biol; 1995 Nov; 19(11):964-5. PubMed ID: 8746067
    [No Abstract]   [Full Text] [Related]  

  • 20. HBV prophylaxis: cost/benefit analysis following liver transplantation for HBV-positive liver cirrhosis.
    Golling M; Arnold JC; Rudek B; Mehrabi A; Kraus T; Herfarth C; Klar E
    Transplant Proc; 1998 Nov; 30(7):3316-7. PubMed ID: 9838466
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.